Alpha1-Acid Glycoprotein for the Treatment of Diabetes

摘要

Methods of using alpha-1-acid glycoprotein, or an active derivative, to modulate the blood glucose level in mammals, particularly humans, is described. A therapeutically effective amount of alpha-1-acid glycoprotein is administered to a patient afflicted with Type 1 or Type 2 diabetes to lower the blood glucose level. An anti-diabetic medicament, particularly insulin, may also be administered in combination with alpha-1-acid glycoprotein. The invention also provides a treatment regimen by periodically administering alpha-1-acid glycoprotein and further provides a method of mitigating the inhibitory effect of an acute phase protein on the action of insulin. Finally, the invention provides for the use of alpha-1-acid glycoprotein or an active derivative for the manufacture of a medicament for the treatment of diabetes, for the manufacture of a medicament for mitigating the hyperglycemic effect of an acute phase protein, or for the manufacture of a medicament for the treatment of chronic or sub-chronic inflammation.